http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2012528121-A

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D239-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5377
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D239-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-506
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D405-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
filingDate 2010-05-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2012-11-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-2012528121-A
titleOfInvention 2,4-Diaminopyrimidine for the treatment of diseases characterized by excessive or abnormal cell proliferation
abstract 【Task】 Novel compounds suitable for the treatment of diseases characterized by excessive or abnormal cell proliferation are provided. [Solution] The present invention is represented by the general formula (1) [Chemical 1] Wherein A, B, R 1 to R 5 , R x , m, n and p are as defined in claim 1, pharmaceutical formulations containing such compounds and those as drugs Including the use of [Selection figure] None
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-7065840-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2019518796-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11524955-B2
priorityDate 2009-05-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2005509624-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2011518157-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005256145-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2008544972-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008049123-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007132010-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410467209
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID161247898
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2782774
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID431002330
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID58201003
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2725045
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID416193837
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453248207
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID58200992
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID423676465
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID412308451
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22874977
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57753192
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID465517210
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID465905532
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420743381
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID88881893
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID164077771
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420332851

Total number of triples: 55.